NORDIC BIOTECH AS

Signals

2 flags

• ▼ Negativ egenkapital 2024 Bokført egenkapital er negativ (−59k kr).
• ▼ Driftsunderskudd 2024 Siste driftsresultat er negativt (−20k kr).

NORDIC BIOTECH AS is registered as a limited company in Oslo, Oslo with organisation number 828353152. The business is classified under business and other management consultancy activities (NACE 70.200). The company was incorporated in 2021. Registered share capital is NOK 30,000, divided into 100000 shares. The company's stated purpose is: “Investeringer, kjøp og salg av verdipapirer.”. The most recent filed accounts, for the 2024 financial year, show NOK 0 in revenue and NOK −20,000 in operating profit.

Key figures · 2024

Revenue

NOK 0

Operating profit

NOK −20,000

Equity

NOK −59,000

Financial health · 2024

Liquidity

0.91

Weak

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

-42.4%

Weak

Equity as a share of total capital

Solidity capped at Weak because equity is below NOK 100,000.

Who owns NORDIC BIOTECH AS?

PATHFINDER AS

97.5%

NORDIC BIOTECH AS

NOK 0 rev. · NOK −20,000 profit

NORDIC BIOTECH AS has 2 registered shareholders:

• PATHFINDER AS 97.5%
• JAN MESICEK 2.5%

All shareholders and roles →

Frequently asked questions about NORDIC BIOTECH AS

Who owns NORDIC BIOTECH AS?

PATHFINDER AS is the largest registered owner, with 97.5%.

What is the revenue of NORDIC BIOTECH AS?

NORDIC BIOTECH AS had revenue of NOK 0 in 2024.

Who is the general manager of NORDIC BIOTECH AS?

Geir Arne Børresen is registered as general manager of NORDIC BIOTECH AS.

Where is NORDIC BIOTECH AS based?

NORDIC BIOTECH AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.